Pfizer Fined $60 Million Over Kickbacks Paying Doctors to Push Drugs onto Patients

Pharmaceutical giant Pfizer has been ordered to pay almost $60 million in fines over a kickback scheme that paid doctors to push drugs onto their patients.

The fines are a resolution to accusations a company Pfizer acquired paid doctors to prescribe a migraine medication.

The medication is marketed as Nurtec ODT, also known as Rimegepant.

The drug was endorsed in television commercials by the celebrities Whoopi Goldberg and Lady Gaga.

WATCH:

TOP DEAL FROM PREMIUM GADGET STORE

The kickback scheme took place from March 1, 2020, until September 30, 2022, and was orchestrated by Biohaven Pharmaceutical Holding which owned the drug then.

Pfizer acquired Biohaven in October of 2022.

“The settlement relates to alleged conduct at Biohaven before Pfizer acquired the company in October 2022 and does not include any admission of liability or wrongdoing,” a Pfizer spokesperson said.

“We are pleased to put this legacy matter behind us so that we can continue to focus on the needs of patients.”

Prosecutors allege the kickback scheme involved Biohaven providing doctors with “improper remuneration” in the form of speaker payments.

Doctors also received high-end meals at expensive restaurants as the company sought to get the physicians to prescribe Nurtec.

Slay the latest News for free!

We don’t spam! Read our privacy policy for more info.

As reported in the Wall Street Journal, the federal anti-kickback statute prohibits companies from paying doctors or offering them anything of value to persuade the doctors to prescribe the referral of drugs or services paid for by Medicare, Medicaid, or any federal healthcare program.

The statute is intended to ensure the judgment of medical providers is not compromised by “improper financial incentives”.

The Department of Justice (DOJ) issued a statement warning doctors and drug companies against such arrangements.

In the statement, Acting Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division said:

“Through this settlement and others, the government has demonstrated its commitment to ensuring that drug companies do not use kickbacks to influence physician prescribing.

“The department will use every tool at its disposal to prevent pharmaceutical manufacturers from undermining the objectivity of treatment decisions by health care providers.”

The kickbacks stopped when Pfizer ended Biohaven’s Nurtec speaker program.

However, there is a lingering question of whether this is the only instance of doctors receiving payment to prescribe a particular medication.

This kind of behavior further erodes trust in the medical industry.

Given the amount of revenue and profit generated by Pfizer during the pandemic, it raises concerns over the company’s kickback schemes to promote Covid mRNA “vaccines.”

As reported in an April 2023 Substack piece, Pfizer made donations lobbying around the country to push for Covid “vaccine” mandates and the use of its mRNA injections.

Pfizer “doled” out money throughout the United States to consumer groups, doctors, medical groups, civil rights organizations, and public health organizations.

Many of the organizations never disclosed the “donations” they got from the pharmaceutical giant while they were advocating for vaccine mandates.

While staying in the background, Pfizer was able to get widespread support from public officials to make its Covid “vaccine,” one of the most profitable “medicines” in history.

The company generated over $36.7 billion in revenue from the shot.

The mandates pushed by cities during the pandemic resulted in the loss of jobs for municipal workers for their refusal to take the “vaccine.”

Pfizer did their best to maintain excellent public relations by going as far as offering their anti-viral drug Paxlovid for free on the streets of New York, despite the medication’s “rebound effect.”

During the pandemic, Pfizer used adhesion contracts to exploit and capitalize on the pandemic.

Via the ICAM protocol, the pharmaceutical company used contracts to block the use of repurposed drugs in whole health systems early in the pandemic.

Meaning the company contractually bound health systems if they sought to access the Pfizer Covid “vaccine” and Paxlovid clinical trials.

The company and others will continue to wield their position, networks, capital, and power to advance growth and profits.

If executive management does not, shareholders will oust them.

It comes amid hope that Robert F. Kennedy Jr. be able to turn around America’s health system under the Trump administration.

However, Kennedy still faces stiff opposition to his confirmation in the Senate.

As it states, RFK Jr. has about a 50% chance of making it through.

READ MORE – WEF Demands General Public Mass-Vaccinated ‘Every 6 Months’ with ‘Long-Acting’ mRNA Injections

SHARE:
join telegram

READERS' POLL

Who is the best president?

By completing this poll, you gain access to our free newsletter. Unsubscribe at any time.

Subscribe
Notify of

Recommended

9
0
Would love your thoughts, please comment.x
()
x